Evidence map›Paper›PMID 39001551›Full record

ArticleCancers2024

A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity.

Menghan Wang, Yanqi Xie, Jinpeng Liu, Austin Li, Li Chen, Arnold Stromberg, Susanne M Arnold, Chunming Liu, Chi Wang

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Menghan WangDepartment of Statistics, University of Kentucky, Lexington, KY 40536, USA.ORCID 0009-0001-0850-919X
Yanqi XieDepartment of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, KY 40508, USA.ORCID 0000-0002-9887-0084
Jinpeng LiuMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0003-4100-0237
Austin LiDepartment of Computer Science, Princeton University, Princeton, NJ 08540, USA.
Li ChenMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Arnold StrombergDepartment of Statistics, University of Kentucky, Lexington, KY 40536, USA.
Susanne M ArnoldMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Chunming LiuDepartment of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, KY 40508, USA.
Chi WangDepartment of Statistics, University of Kentucky, Lexington, KY 40536, USA.

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Institutional Career Development CoreKL2TR001996 · NCATS · UNIVERSITY OF KENTUCKY · PI BUSH, MATTHEW LEE, KELLY, THOMAS H. · 2016 to 2025
$7.1M
Statistical methods for cancer progression delineation and subtype identificationR03CA259670 · NCI · UNIVERSITY OF KENTUCKY · PI WANG, CHI · 2021 to 2022
$150k
NCATS NIH HHS KL2 TR001996NCI NIH HHS P30 CA177558NCI NIH HHS R03 CA259670NIH HHS R03CA259670NIH HHS UL1TR001998the Biostatistics and Bioinformatics Shared Resource Facility of the University of Kentucky Markey Cancer Center P30CA177558
6 · The paper itself

Abstract

The development of cancer involves the accumulation of somatic mutations in several essential biological pathways. Delineating the temporal order of pathway mutations during tumorigenesis is crucial for comprehending the biological mechanisms underlying cancer development and identifying potential targets for therapeutic intervention. Several computational and statistical methods have been introduced for estimating the order of somatic mutations based on mutation profile data from a cohort of patients. However, one major issue of current methods is that they do not take into account intra-tumor heterogeneity (ITH), which limits their ability to accurately discern the order of pathway mutations. To address this problem, we propose PATOPAI, a probabilistic approach to estimate the temporal order of mutations at the pathway level by incorporating ITH information as well as pathway and functional annotation information of mutations. PATOPAI uses a maximum likelihood approach to estimate the probability of pathway mutational events occurring in a specific sequence, wherein it focuses on the orders that are consistent with the phylogenetic structure of the tumors. Applications to whole exome sequencing data from The Cancer Genome Atlas (TCGA) illustrate our method's ability to recover the temporal order of pathway mutations in several cancer types.

Indexed as

cancer mutationsintra-tumor heterogeneitypathway analysis

Identifiers

PMID39001551
PMCPMC11240401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.